Status:
TERMINATED
Tapentadol Versus Oxycodone - a Mechanism-based Treatment Approach in Neuropathic Pain
Lead Sponsor:
University Hospital Schleswig-Holstein
Conditions:
Peripheral Neuropathy
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to elucidate whether the additional mechanism of analgesia, i.e. reuptake inhibition of norepinephrine, of tapentadol leads to a change in different pain signs and symptom...
Eligibility Criteria
Inclusion
- thermal or mechanical hyperalgesia
- chronic neuropathic pain (NRS =\> 6)
Exclusion
- non-specific
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT01458015
Start Date
October 1 2011
End Date
November 1 2013
Last Update
January 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division for Neurological Pain Research and Therapy
Kiel, Schleswig-Holstein, Germany, 24105